Minoxidil and Etodolac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minoxidil (minoxidil) and Etodolac (etodolac). Common drug interactions include chronic kidney disease among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Minoxidil and Etodolac. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 29,925 Minoxidil users. Check the latest studies of Minoxidil.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

14 people who take Minoxidil and Etodolac together, and have interactions are studied.

Minoxidil and Etodolac drug interactions.

What are the common drug interactions of Minoxidil and Etodolac, by gender? *:

female:

Chronic kidney disease
Dry skin
Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Nephrogenic anaemia (anaemia due to kidney disease)
Rash erythematous (redness of the skin)
Renal failure (kidney dysfunction)
Wound

male:

Renal failure (kidney dysfunction)
Chronic kidney disease
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Osteodystrophy (a dystrophic growth of the bone)
Renal tubular disorder (disease of kidney tubules)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Constipation
Diarrhoea

What are the common drug interactions of Minoxidil and Etodolac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Renal failure (kidney dysfunction)
Chronic kidney disease
Dyspepsia (indigestion)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Osteodystrophy (a dystrophic growth of the bone)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Nephrogenic anaemia (anaemia due to kidney disease)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

Fatigue (feeling of tiredness)
Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Rash erythematous (redness of the skin)
Renal tubular disorder (disease of kidney tubules)
Constipation
Diarrhoea
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Renal failure (kidney dysfunction)
Dry skin

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 57.14%
Pain: 7 people, 50.00%
High Blood Pressure: 5 people, 35.71%
Muscle Spasms (muscle contraction): 3 people, 21.43%
High Blood Cholesterol: 3 people, 21.43%
Heart Disease: 2 people, 14.29%
Diabetes: 2 people, 14.29%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 2 people, 14.29%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 14.29%
Cardiac Failure: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Minoxidil and Etodolac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously